Saber Yousefi

Saber Yousefi

Auto-generated profile, based on publicly available information

Saber Yousefi

Department of Microbiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
SYSaber Yousefi
Saber Yousefi
SFSafar Farajnia
Safar Farajnia
MNMohammd Reza Nahaei
Mohammd Reza Nahaei
MAMohammad Taghi Akhi
Mohammad Taghi Akhi
RGReza Ghotaslou
Reza Ghotaslou
NJNima Hosseini Jazani
Nima Hosseini Jazani

17 July 2012 in APMIS
Verified
Journal Article
Closed access
PDF file
SYSaber Yousefi
Saber Yousefi
MNMohammad Reza Nahaei
Mohammad Reza Nahaei
SFSafar Farajnia
Safar Farajnia
MAMohammad Aghazadeh
Mohammad Aghazadeh
AIAina Iversen
Aina Iversen
CGChristian G. Giske
Christian G. Giske

1 September 2010
Verified
Journal Article
Open access
SYS Yousefi
S Yousefi
MNM. R. Nahaei
M. R. Nahaei
SFS. Farajnia
S. Farajnia
MGM. Ghojazadeh
M. Ghojazadeh
MAM. T. Akhi
M. T. Akhi
RGReza Ghotaslou
Reza Ghotaslou
Background and Objectives: Pseudomonas aeruginosa is one of the most important causative agents of nosocomial infections especially in ICU and burn units. P. aeruginosa infections are normally difficult to eradicate due to acquired resistance to many antibiotics. Recent appearance of carbapenem resistant P. aeruginosa isolates is considered a major healthcare problem. The present study was conducted to detect class 1 integron and antibiotic susceptibility profiles of imipenem-sensitive and resistant clinical isolates of P. aeruginosa. Materials and Methods: Antibiotic susceptibility profiles and minimum inhibitory concentration against imipenem was studied in 160 clinical isolates of P. aeruginosa by disk agar diffusion method and Etest, respectively. Detection of class 1 integron was performed by the PCR method. Demographic and microbiological data were compared between imipenem susceptible and non-susceptible isolates by the SPSS software. Results: PCR results showed that 90 (56.3%) of P. aeruginosa isolates carried class 1 integron. Antibiotic susceptibility results revealed that 93 (58.1%) were susceptible and 67 (41.9%) were non-susceptible to imipenem. Comparison of antibiotic susceptibility patterns showed high level of drug resistance among imipenem non-susceptible isolates. We found that MDR phenotype, presence of class 1 integron and hospitalization in ICU and burn units were significantly associated with imipenem non-susceptible isolates. Conclusion: The high frequency of imipenem resistance was seen among our P. aeruginosa isolates. Since carbapenems are considered as the last drugs used for treatment of P. aeruginosa infections, it is crucial to screen imipenem non-susceptible isolates in infection control and optimal therapy.

22 July 2016 in Journal of Chemotherapy
Verified
Journal Article
Closed access
MAMohammad Taghi Akhi
Mohammad Taghi Akhi
YKYounes Khalili
Younes Khalili
RGReza Ghotaslou
Reza Ghotaslou
Hossein Samadi KafilHossein Samadi Kafil
Hossein Samadi Kafil
SYSaber Yousefi
Saber Yousefi
HGHamid Reza Goli
Hamid Reza Goli
This investigation was undertaken to compare phenotypic and molecular methods for detection of carbapenemase-producing Pseudomonas aeruginosa. A total of 245 non-duplicated isolates of P. aeruginosa were collected from hospitalized patients. Disc diffusion method was used to identify carbapenem-resistant bacteria. Three phenotypic methods, including Modified Hodge Test (MHT), Modified Carba NP (MCNP) test and Carbapenem Inactivation Method (CIM) were used for investigation of carbapenemase production. In addition, polymerase chain reaction (PCR) was used to detect carbapenemase encoding genes. Of 245 P. aeruginosa isolates investigated, 121 isolates were carbapenem-resistant. Among carbapenem-resistant isolates, 40, 39 and 35 isolates exhibited positive results using MHT, MCNP test and CIM, respectively. PCR indicated the presence of carbapenemase genes in 35 of carbapenem-resistant isolates. MHT showed low sensitivity and specificity for carbapenemase detection among P. aeruginosa isolates in comparison to PCR. CIM was most affordable and highly specific than MCNP test compared with the molecular method.

25 January 2018 in APMIS
Verified
Journal Article
Closed access
PDF file
FMFatemeh Mansouri
Fatemeh Mansouri
RHRasoul Heydarzadeh
Rasoul Heydarzadeh
SYSaber Yousefi
Saber Yousefi

1 March 2018 in Microbial Drug Resistance
Verified
Journal Article
Closed access
MAMohammad Taghi Akhi
Mohammad Taghi Akhi
YKYounes Khalili
Younes Khalili
RGReza Ghotaslou
Reza Ghotaslou
SYSaber Yousefi
Saber Yousefi
Hossein Samadi KafilHossein Samadi Kafil
Hossein Samadi Kafil
VSVajihe Sheikhalizadeh
Vajihe Sheikhalizadeh
The aims of this study were to determine carbapenem resistance mechanisms, molecular epidemiological relationship, clinical impact, and patient outcome of carbapenem-resistant Pseudomonas aeruginosa (CRPA) infections. A total of 42 nonduplicated CRPA were recovered from Urmia, Iran. Antimicrobial susceptibility tests were carried out using phenotypic methods. The carbapenem resistance mechanisms such as carbapenemase genes, efflux pump hyperexpression, AmpC overproduction, and OprD gene downregulation were determined by phenotypic and molecular methods. Eighteen metallo-β-lactamase (MBL) producer isolates were found to be sensitive to amikacin. Among the CRPA, 52.3%, 26.1%, 26.1%, and 59.5% were identified as carbapenemase, efflux pump hyperexpression, AmpC overproduction, and reduced expression OprD gene, respectively. Random Amplified Polymorphic DNA analysis yielded 25 distinct profiles. Most MBL-positive isolates were recovered from patients hospitalized in urology and internal wards with urinary tract infections. Most of the strains showed downregulation of porin. The clonal distribution of the strains was related to carbapenem resistance mechanisms (most of MBL producers belong to the same clones) and the same hospital wards where the isolates were collected. The study demonstrates that the main risk factor of MBL-related infections was hospitalization in non-intensive wards. Amikacin was considered a very efficient antibiotic to treatment of MBL-producing CRPA isolates. Our results showed that OprD downregulation and IMP-type MBL are the main carbapenem resistance mechanisms in CRPA isolates from northwest of Iran.